All In Biotech

Drug Trial Radar · NCT04675294

Evorpacept (ALX148) in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)

A Phase 2 Study of ALX148 in Combination With Pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma (ASPEN-03)

Last checked: Nov 19, 2026Latest source record: Aug 1, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 189 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

189

Actual

Start

Apr 2, 2021

Primary completion

Mar 3, 2025

Study completion Jun 30, 2026

Sponsor

Lead sponsor
ALX Oncology Inc.Industry
Sponsor type
Industry
Collaborators
Merck Sharp & Dohme LLC
First posted
Dec 19, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

A Phase 2 Study of evorpacept (ALX148) in Combination With pembrolizumab in Patients With Advanced Head and Neck Squamous Cell Carcinoma.

Conditions

  • Head and Neck Cancer
  • Head and Neck Squamous Cell Carcinoma

Interventions

  • evorpaceptDrug

    IV Q3W

  • pembrolizumabDrug

    IV Q3W

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Objective response rate per RECIST 1.1Time frame: Last randomized patient reaching at least 24 weeks of follow-up

Locations

53 sites in 9 countries. Site status is shown where the registry gives one.

  • Hoag Hospital

    Irvine, California

  • University of California San Diego

    La Jolla, California

  • H. Lee Moffitt Cancer Center

    Tampa, Florida

  • Northwest Georgia Oncology Centers

    Marietta, Georgia

  • Rush University Medical Center

    Chicago, Illinois

  • Blessing Cancer Center

    Quincy, Illinois

  • University of Maryland Medical System

    Baltimore, Maryland

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Rutgers Cancer Institute of New Jersey

    Newark, New Jersey

  • Memorial Sloan-Kettering Cancer Center

    Long Island City, New York

  • The Ohio State University

    Columbus, Ohio

  • Oregon Health & Science University

    Portland, Oregon

  • Vanderbilt - Ingram Cancer Center

    Nashville, Tennessee

  • Houston Methodist Cancer Center

    Houston, Texas

  • Ashford Cancer Centre Research

    Windsor Gardens, Australia

  • St. Vincent's

    Sydney, New South Wales, Australia

  • Royal Brisbane and Womens Hospital

    Brisbane, Queensland, Australia

  • Peter MacCallum Cancer Centre

    Melbourne, Victoria, Australia

  • Sir Charles Gairdner Hospital

    Perth, Western Australia, Australia

  • Cliniques Universitaires Saint-Luc

    Brussels, Belgium

  • AZ Groeninge

    Kortrijk, Belgium

  • UZ Leuven

    Leuven, Belgium

  • Hamilton Health Sciences - Juravinski Cancer Centre

    Hamilton, Ontario, Canada

  • LHSC - Victoria Hospital

    London, Ontario, Canada

  • Ottawa Hospital Cancer Centre

    Ottawa, Ontario, Canada

  • Princess Margaret Cancer Centre

    Toronto, Ontario, Canada

  • VUMC Goederenontvangst

    Amsterdam, Netherlands

  • Universitair Medisch Centrum Groningen

    Groningen, Netherlands

  • National University Cancer Institute

    Singapore, Singapore

  • National Cancer Centre Singapore

    Singapore, Singapore

  • Chungbuk National University Hospital

    Cheongju-si, South Korea

  • Yeungnam University Medical Center

    Daegu, South Korea

  • Chungnam National University Hospital

    Daejeon, South Korea

  • CHA University of Bundang

    Gyeonggi-do, South Korea

  • Gachon University - Gil Medical Center

    Incheon, South Korea

  • Seoul National University Bundang Hospital

    Seongnam, South Korea

  • Korea University Medical Center (KUMC) - Korea University Anam Hospital

    Seoul, South Korea

  • Seoul National University Hospital

    Seoul, South Korea

  • The Catholic University of Korea - Eunpyeong St. Mary's Hospital

    Seoul, South Korea

  • Samsung Medical Center

    Seoul, South Korea

Showing 40 of 53 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.